B
Björn Zackrisson
Researcher at Umeå University
Publications - 93
Citations - 3545
Björn Zackrisson is an academic researcher from Umeå University. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 30, co-authored 89 publications receiving 2882 citations. Previous affiliations of Björn Zackrisson include University College London & Sahlgrenska University Hospital.
Papers
More filters
Journal ArticleDOI
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark,Adalsteinn Gunnlaugsson,Lars Beckman,Camilla Thellenberg-Karlsson,Morten Høyer,Magnus Lagerlund,Jon Kindblom,Claes Ginman,Bengt Johansson,Kirsten Björnlinger,Mihajl Seke,Måns Agrup,Per Fransson,Björn Tavelin,David Norman,Björn Zackrisson,Harald Anderson,Elisabeth Kjellén,Lars Franzén,Per Nilsson +19 more
TL;DR: There was weak evidence of an increased frequency of acute physician-reported RTOG grade 2 or worse urinary toxicity in the ultra-hypofractionation group at end of radiotherapy, consistent with the physician-evaluated toxicity.
Journal ArticleDOI
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Benjamin Lacas,Jean Bourhis,Jens Overgaard,Qiang Zhang,Vincent Grégoire,Matthew Nankivell,Björn Zackrisson,Z. Szutkowski,Rafał Suwiński,Michael Poulsen,Brian O'Sullivan,Renzo Corvò,Sarbani Ghosh Laskar,Carlo Fallai,Hideya Yamazaki,W. Dobrowsky,Kwan Ho Cho,Adam S. Garden,Johannes A. Langendijk,Celia Maria Pais Viegas,John Hay,Mohamed Lotayef,Mahesh K. B. Parmar,Anne Auperin,Carla van Herpen,Philippe Maingon,Andy Trotti,Cai Grau,Jean-Pierre Pignon,Pierre Blanchard +29 more
TL;DR: This update confirms, with more patients and a longer follow-up than the first version of MARCH, that hyperfractionated radiotherapy is, along with concomitant chemoradiotherapy, a standard of care for the treatment of locally advanced head and neck squamous cell cancers.
Journal ArticleDOI
Dedicated magnetic resonance imaging in the radiotherapy clinic
TL;DR: The new logistics model with an integrated MR unit is efficient and will allow for improved tumor definition and geometrical precision without a significant loss of dosimetric accuracy.
Journal ArticleDOI
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis
Adrian C. Begg,Karin Haustermans,August A. M. Hart,Stan Dische,Michele I. Saunders,Björn Zackrisson,Hans Gustaffson,Philippe Coucke,Nicolas Paschoud,Morten Høyer,Jens Overgaard,Paolo Antognoni,Antonella Richetti,Jean Bourhis,Harry Bartelink,Jean-Claude Horiot,Renzo Corvò,Walter Giaretti,Hassan K. Awwad,Tarek Shouman,Thomas Jouffroy,Zofia Maciorowski,W. Dobrowsky,Henk Struikmans,Derk H. Rutgers,George S. Wilson +25 more
TL;DR: It appears that pretreatment cell kinetic measurements carried out using flow cytometry, only provide a relatively weak predictor of outcome after radiotherapy in head and neck cancer.
Journal ArticleDOI
A systematic overview of radiation therapy effects in head and neck cancer.
TL;DR: This synthesis of the literature on radiation therapy for head and neck cancer is based on data from 39 randomized trials and 1 meta-analysis, and there is insufficient evidence that radioprotective agents offer clinically significant protection of parotid glands.